Balyasny Asset Management LLC Biogen Inc. Call Options Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $7.16 Million - $8.27 Million	26,000 New	26,000 $7.41 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $9.49 Million - $12 Million	49,000 Added 52.69%	142,000 $29.9 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5.82 Million - $7.48 Million	-26,000 Reduced 21.85%	93,000 $22.3 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $27.2 Million - $35.4 Million	96,000 Added 417.39%	119,000 $33.7 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $777,000 - $1.24 Million	-3,000 Reduced 11.54%	23,000 $7.96 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.94 Million - $2.28 Million	-8,000 Reduced 23.53%	26,000 $7.27 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $7.21 Million - $10.8 Million	-30,500 Reduced 47.29%	34,000 $8.33 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.46 Million - $1.68 Million	-5,500 Reduced 7.86%	64,500 $18.3 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $1.1 Million - $1.52 Million	-5,000 Reduced 6.67%	70,000 $20.8 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $657,870 - $725,160	3,000 Added 4.17%	75,000 $17.9 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $10.4 Million - $16.3 Million	48,000 Added 200.0%	72,000 $17 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $42.1 Million - $50.2 Million	-163,500 Reduced 87.2%	24,000 $6.97 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $650,325 - $919,775	2,500 Added 1.35%	187,500 $51.3 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $56.9 Million - $63.7 Million	185,000	185,000 $58.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account